Sumati V. Gupta - Publications

SWI/SNF Alterations Define a Chromatin-Dependent Subtype of Urothelial Carcinoma.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional Analysis.

Journal: Cancers

Published: March 28, 2026

Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a cross-sectional analysis.

Journal: medRxiv : the preprint server for health sciences

Published: January 16, 2026

Identification of Circulating Lipidomic Biomarkers of Malnutrition Risk among Oncology Patients in the Total Cancer Care (TCC) Study: A Cross-Sectional Analysis.

Journal: The Journal of nutrition

Published: January 12, 2026

Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: January 09, 2026

Allostatic Load, Multimorbidity, and Overall and Cancer-Specific Survival among Older Adults in the United States.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: December 22, 2025

Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations.

Journal: JAMA network open

Published: October 02, 2025

Germline whole-exome sequencing reveals FOXP3-related gene variants conferring urinary cancer susceptibility and associated with immune escape.

Journal: Journal for immunotherapy of cancer

Published: August 24, 2025

ShinyEvents: harmonizing longitudinal data for real world survival estimation.

Journal: Research square

Published: August 13, 2025

ShinyEvents: harmonizing longitudinal data for real-world survival estimation.

Journal: NPJ precision oncology

Published: July 28, 2025

Response to: Comment on "Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)".

Journal: Journal for immunotherapy of cancer

Published: May 09, 2025

Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT).

Journal: Journal for immunotherapy of cancer

Published: March 06, 2025